277
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Enhanced MHC class I and costimulatory molecules on B16F10 cells by Ganoderma lucidum polysaccharides

, , , , , , , , , , & show all
Pages 582-592 | Received 24 Dec 2011, Accepted 22 May 2012, Published online: 14 Jun 2012

References

  • Bubeník J. (2004). MHC class I down-regulation: tumour escape from immune surveillance? (review). Int J Oncol, 25, 487–491.
  • Cao LZ, Lin ZB. (2002). Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett, 83, 163–169.
  • Cao LZ, Lin ZB. (2003). Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol Sin, 24, 321–326.
  • Cao QZ, Lin ZB. (2006). Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci, 78, 1457–1463.
  • Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. (2005). Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev, 207, 145–157.
  • Chambers CA, Kuhns MS, Egen JG, Allison JP. (2001). CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol, 19, 565–594.
  • Chan WK, Law HK, Lin ZB, Lau YL, Chan GC. (2007). Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley. Int Immunol, 19, 891–899.
  • Costello RT, Gastaut JA, Olive D. (1999). Tumor escape from immune surveillance. Arch Immunol Ther Exp (Warsz), 47, 83–88.
  • Das S, Ng KY, Ho PC. (2011). Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitroand in vivoevaluations. J Drug Target, 19, 446–457.
  • Frauwirth KA, Thompson CB. (2002). Activation and inhibition of lymphocytes by costimulation. J Clin Invest, 109, 295–299.
  • Gajewski TF. (2007). Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment. Clin Cancer Res, 13, 5256–5261.
  • García-Lora A, Algarra I, Collado A, Garrido F. (2003). Tumour immunology, vaccination and escape strategies. Eur J Immunogenet, 30, 177–183.
  • Geldenhuys W, Mbimba T, Bui T, Harrison K, Sutariya V. (2011). Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. J Drug Target, 19, 837–845.
  • Ghosh S, Das Sarma M, Patra A, Hazra B. (2010). Anti-inflammatory and anticancer compounds isolated from Ventilago madraspatanaGaertn., Rubia cordifoliaLinn. and Lantana camaraLinn. J Pharm Pharmacol, 62, 1158–1166.
  • Greenfield EA, Nguyen KA, Kuchroo VK. (1998). CD28/B7 costimulation: a review. Crit Rev Immunol, 18, 389–418.
  • Gross S, Walden P. (2008). Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer. Immunol Lett, 116, 7–14.
  • Hagerty DT, Evavold BD, Allen PM. (1994). Regulation of the costimulator B7, not class II major histocompatibility complex, restricts the ability of murine kidney tubule cells to stimulate CD4+ T cells. J Clin Invest, 93, 1208–1215.
  • Hsieh TC, Wu JM. (2011). Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidumin the ovarian cancer cell line OVCAR-3. Int J Mol Med, 28, 1065–1069.
  • Kobayashi A, Hara H, Ohashi M, Nishimoto T, Yoshida K, Ohkohchi N, Yoshida T, Aoki K. (2007). Allogeneic MHC gene transfer enhances an effective antitumor immunity in the early period of autologous hematopoietic stem cell transplantation. Clin Cancer Res, 13, 7469–7479.
  • Kohm AP, Mozaffarian A, Sanders VM. (2002). B cell receptor- and beta 2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J Immunol, 168, 6314–6322.
  • Kour K, Sangwan PL, Sangwan PL, Khan I, Koul S, Sharma SN, Kitchlu S, Bani S. (2011). Alcoholic extract of Cicer microphyllumaugments Th1 immune response in normal and chronically stressed Swiss albino mice. J Pharm Pharmacol, 63, 267–277.
  • Li J, Cheng Y, Qu W, Sun Y, Wang Z, Wang H, Tian B. (2011a). Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells. Basic Clin Pharmacol Toxicol, 108, 84–93.
  • Li QQ, Wang G, Reed E, Huang L, Cuff CF. (2010). Evaluation of cisplatin in combination with ß-Elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol, 107, 868–876.
  • Li F, Zhang Y, Zhong Z. (2011b). Antihyperglycemic effect of Ganoderma lucidumpolysaccharides on streptozotocin-induced diabetic mice. Int J Mol Sci, 12, 6135–6145.
  • Li WD, Zhang BD, Wei R, Liu JH, Lin ZB. (2008). Reversal effect of Ganoderma lucidumpolysaccharide on multidrug resistance in K562/ADM cell line. Acta Pharmacol Sin, 29, 620–627.
  • Lin ZB, Zhang HN. (2004). Anti-tumor and immunoregulatory activities of Ganoderma lucidumand its possible mechanisms. Acta Pharmacol Sin, 25, 1387–1395.
  • McGowan EM, Alling N, Jackson EA, Yagoub D, Haass NK, Allen JD, Martinello-Wilks R. (2011). Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: pitfalls of the MTS assay. PLoS ONE, 6, e20623.
  • Mey-Tal SV, Schechter C, Ehrlich R. (1997). Synthesis and turnover of beta2-microglobulin in Ad12-transformed cells defective in assembly and transport of class I major histocompatibility complex molecules. J Biol Chem, 272, 353–361.
  • Mooberry LK, Nair M, Paranjape S, McConathy WJ, Lacko AG. (2010). Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. J Drug Target, 18, 53–58.
  • Nurieva R, Thomas S, Nguyen T, Martin-Orozco N, Wang Y, Kaja MK, Yu XZ, Dong C. (2006). T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J, 25, 2623–2633.
  • Ohtsuka M, Inoko H, Kulski JK, Yoshimura S. (2008). Major histocompatibility complex (Mhc) class Ib gene duplications, organization and expression patterns in mouse strain C57BL/6. BMC Genomics, 9, 178.
  • Pamer E, Cresswell P. (1998). Mechanisms of MHC class I–restricted antigen processing. Annu Rev Immunol, 16, 323–358.
  • Pang X, Chen Z, Gao X, Liu W, Slavin M, Yao W, Yu LL. (2007). Potential of a novel polysaccharide preparation (GLPP) from Anhui-grown Ganoderma lucidumin tumor treatment and immunostimulation. J Food Sci, 72, S435–S442.
  • Restifo NP, Kawakami Y, Marincola F, Shamamian P, Taggarse A, Esquivel F, Rosenberg SA. (1993). Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I. J Immunother Emphasis Tumor Immunol, 14, 182–190.
  • Salomon B, Bluestone JA. (2001). Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol, 19, 225–252.
  • Sarrabayrouse G, Pich C, Moriez R, Armand-Labit V, Rochaix P, Favre G, Tilkin-Mariamé AF. (2010). Melanoma cells treated with GGTI and IFN-gamma allow murine vaccination and enhance cytotoxic response against human melanoma cells. PLoS ONE, 5, e9043.
  • Shao BM, Dai H, Xu W, Lin ZB, Gao XM. (2004). Immune receptors for polysaccharides from Ganoderma lucidum. Biochem Biophys Res Commun, 323, 133–141.
  • Song J, Lei FT, Xiong X, Haque R. (2008). Intracellular signals of T cell costimulation. Cell Mol Immunol, 5, 239–247.
  • Sun LX, Chen LH, Lin ZB, Qin Y, Zhang JQ, Yang J, Ma J, Ye T, Li WD. (2011a). Effects of Ganoderma lucidumpolysaccharides on IEC-6 cell proliferation, migration and morphology of differentiation benefiting intestinal epithelium healing in vitro. J Pharm Pharmacol, 63, 1595–1603.
  • Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Li XJ, Li M, Xing EH, Jia J, Lan TF, Li WD. (2011b). Ganoderma lucidumpolysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells. J Pharm Pharmacol, 63, 725–735.
  • Sun LX, Lin ZB, Li XJ, Li M, Lu J, Duan XS, Ge ZH, Song YX, Xing EH, Li WD. (2011c). Promoting effects of Ganoderma lucidumpolysaccharides on B16F10 cells to activate lymphocytes. Basic Clin Pharmacol Toxicol, 108, 149–154.
  • Sun LX, Lin ZB, Duan XS, Lu J, Ge ZH, Song YX, Li XJ, Li M, Xing EH, Yang N, Li WD. (2012). Stronger cytotoxicity in CTLs with granzyme B and porforin was induced by Ganoderma lucidumpolysaccharides acting on B16F10 cells. Biomed Prev Nutr, 2, 113–118 DOI: 10.1016/j.bionut.2012.01.001.
  • Tham EL, Jensen PL, Mescher MF. (2001). Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins. J Immunol Methods, 249, 111–119.
  • Thomas AK, Maus MV, Shalaby WS, June CH, Riley JL. (2002). A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes. Clin Immunol, 105, 259–272.
  • Tilkin-Mariamé AF, Cormary C, Ferro N, Sarrabayrouse G, Lajoie-Mazenc I, Faye JC, Favre G. (2005). Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expression. FASEB J, 19, 1513–1515.
  • Wang YY, Zheng XX. (2002). A flow cytometry-based assay for quantitative analysis of cellular proliferation and cytotoxicity in vitro. J Immunol Methods, 268, 179–188.
  • You YH, Lin ZB. (2002). Protective effects of Ganoderma lucidumpolysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacol Sin, 23, 787–791.
  • Zhao H, Luo Y, Lu C, Lin N, Xiao C, Guan S, Guo DA, Liu Z, Ju D, He X, Lu A. (2010). Enteric mucosal immune response might trigger the immunomodulation activity of Ganoderma lucidumpolysaccharide in mice. Planta Med, 76, 223–227.
  • Zhou ZY, Tang YP, Xiang J, Wua P, Jin HM, Wang Z, Mori M, Cai DF. (2010). Neuroprotective effects of water-soluble Ganoderma lucidumpolysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol, 131, 154–164.
  • Zhu XL, Chen AF, Lin ZB. (2007). Ganoderma lucidumpolysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol, 111, 219–226.
  • Zhu XL, Lin ZB. (2005). Effects of Ganoderma lucidumpolysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells. Acta Pharmacol Sin, 26, 1130–1137.
  • Zhu XL, Lin ZB. (2006). Modulation of cytokines production, granzyme B and perforin in murine CIK cells by Ganoderma lucidumpolysaccharides. Carbohydr Polymer, 63, 188–197.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.